Singapore markets closed

Duopharma Biotech Berhad (7148.KL)

Kuala Lumpur - Kuala Lumpur Delayed price. Currency in MYR
Add to watchlist
1.2600+0.0300 (+2.44%)
At close: 04:52PM MYT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
52,645
52,645
70,112
65,683
58,610
Depreciation & amortisation
43,050
43,050
36,197
31,955
29,067
Change in working capital
-46,303
-46,303
-58,290
-61,930
-29,298
Inventory
-12,392
-12,392
-53,361
-78,430
-21,366
Other working capital
9,244
9,244
-756
-71,802
5,732
Other non-cash items
15,447
15,447
8,059
5,751
5,699
Net cash provided by operating activities
48,804
48,804
70,265
43,204
71,348
Cash flows from investing activities
Investments in property, plant and equipment
-39,560
-39,560
-71,021
-115,006
-65,616
Acquisitions, net
0
0
0
0
0
Purchases of investments
-6,421
-6,421
0
-2,070
-21,918
Sales/maturities of investments
-
-
-
0
24,598
Net cash used for investing activities
-43,231
-43,231
-69,500
-115,859
-61,426
Net change in cash
113,093
113,093
18,963
-20,289
37,756
Cash at beginning of period
157,637
157,637
137,980
158,029
120,669
Cash at end of period
270,502
270,502
157,637
137,980
158,029
Free cash flow
Operating cash flow
48,804
48,804
70,265
43,204
71,348
Capital expenditure
-39,560
-39,560
-71,021
-115,006
-65,616
Free cash flow
9,244
9,244
-756
-71,802
5,732